Joseph B Domachowske, MD^1*, Ulrika Wählby Hamren^2*, Bhanu Basavaraju^3*, Anthonet Koen^4*, Amanda Leach^5*, Vaishali S Mankad^6*, Masaaki Mori^7*, Carl Ndibmun^8*, Pere Soler-Palacin^9,10*, Pia S Pannaraj^11*, Therese Takas^8* and Tonya Villafana^8*

¹State University of New York Upstate Medical University, Syracuse, NY
²Clinical Pharmacology and Quantitative Pharmacology, R&D, AstraZeneca, Gothenburg, Sweden
³Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom
⁴South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit (Wits-VIDA), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
⁵AstraZeneca, Gaithersburg, MD
⁶Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Durham, NC
⁷Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
⁸Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD
⁹Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d’Hebron, Barcelona, Catalonia, Spain
¹⁰Vall d’Hebron Research Institute, Barcelona, Catalonia, Spain
¹¹Division of Infectious Diseases, Department of Pediatrics, University of California San Diego, San Diego, CA

Michael B. Jordan, MD¹, Carl Allen^2*, Anupama Rao, MD, MRCPath^3*, Carmelo Rizzari, MD^4*, Simone Cesaro^5*, Maria Caterina Putti^6*, Julian Sevilla, MD, PhD^7*, Cristina de Min^8*, Maria Ballabio^8*, Veronica Asnaghi^8*, Anna Stoltenberg^9*, Radmila Kanceva, MD, PhD^10* and Franco Locatelli, MD, PhD¹¹

¹Divisions of Immunobiology, and Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children’s Hospital, Cincinnati, OH
²Texas Children's Cancer Center, Houston, TX
³Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
⁴Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
⁵Pediatric Hematology-Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
⁶Clinic of Pediatric Hematology-Oncology, Department of Biomedical Sciences, University Hospital of Padova, Padova, ITA
⁷Hospital Universitario Niño Jesús Servicio de Hemato-Oncología Pediátrica, Madrid, ESP
⁸Sobi (former employee), Basel, Switzerland
⁹Sobi, Stockholm, Sweden
¹⁰Sobi, Basel, Switzerland
¹¹Department of Pediatrics, Catholic University of the Sacred Heart, Rome, Italy

Jingshi Wang^1*, Na Wei^2*, Jia Zhang^2*, Lin Wu^1*, Xi Wang^3* and Zhao Wang, MD, PhD²

¹Beijing Friendship Hospital,Capital Medical University, Beijing, China
²Beijing Friendship Hospital,Capital Medical University, Beijing, China, Beijing, China
³State Key Laboratory of Reproductive Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China

Li Li^1*, Mengqi Xiong^1,2*, Lulu Wang^1,2*, Lixia Zhu^1*, Rongrong Chen^1,2*, Jingsong He^1* and Xiu-Jin Ye^1*

¹The Department of Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Program in Clinical Medicine, School of Medicine of Zhejiang University, Hangzhou, China

Xuxiang Liu, PhD^1*, Jibin Zhang, Ph.D.^1*, Yunfei Shi, MD, PhD^2*, Kunal Shetty^1*, Can Kucuk, Ph.D.^3,4,5*, Esra Esmeray^4,5* and Wing C. Chan, MD⁶

¹City of Hope National Medical Center, Duarte, CA
²Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, China
³Department of Medical Biology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey
⁴Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir, Turkey
⁵İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir, Turkey
⁶Department of Pathology, City of Hope National Medical Center, Duarte, CA

Dipabarna Bhattacharya^1,2,3*, Jason Theodoropoulos, M.Sc.^1,2,3,4*, Katariina Nurmi^5*, Timo Juutilainen^6*, Kari K Eklund^5,7*, Riitta Koivuniemi^7*, Tiina Kelkka^1,3*, Satu Mustjoki, MD, PhD^1,2,8,9 and Tapio Lönnberg^10,11*

¹Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland
²ICAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland
³Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
⁴Department of Computer Science, Aalto University, Helsinki, Finland
⁵Faculty of Medicine, Clinicum, Translational Immunology Program, University of Helsinki, Helsinki, Finland
⁶ORTON Orthopaedic Hospital, Helsinki, Helsinki, Finland
⁷Department of Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
⁸Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
⁹Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland
¹⁰Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland
¹¹InFlames Flagship Center, University of Turku, Turku, Finland

Harrison D Collier-Bain, MSc, BSc^1*, Annabelle Emery, PhD^1*, Adam J Causer, PhD^1*, Frankie F Brown, PhD^1,2,3*, Rebecca Oliver, BM BSc^1,4*, David Dutton^5*, Josephine Crowe^4*, Daniel Augustine^6*, John Graby^1,6*, Shoji Leach, BSc^7*, Rachel Eddy^7*, Daniela Rothschild Rodriguez^8*, Juliet C Gray, PhD, MBBS, MA^9*, Mark S Cragg, PhD^10*, Kirstie L Cleary^11*, Sally Moore^12*, James Murray, MBBChir, PhD^4*, James E Turner, PhD^1,13* and John P Campbell, PhD^1*

¹Clinical Rehabilitation and Exercise Medicine, Department for Health, University of Bath, Bath, United Kingdom
²School of Applied Sciences, Edinburgh Napier University, Bristol, United Kingdom
³School of Applied Sciences, Edinburgh Napier University, Edinburgh, United Kingdom
⁴Department of Haematology, Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom
⁵Department for Haematology, Great Western Hospitals NHS Foundation Trust, Swindon, United Kingdom
⁶Department for Cardiology, Royal United Hospitals Bath NHS Foundation Trust, United Kingdom, Bath, United Kingdom
⁷Department for Health, University of Bath, Bath, United Kingdom
⁸School of Biological Sciences, University of Southampton, Southampton, United Kingdom
⁹Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton, United Kingdom, Southampton, United Kingdom
¹⁰Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom
¹¹Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton, Southampton, GBR
¹²Department of Haematology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
¹³School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom

Betul Ibis^1*, Anthos Christofides, MD^1,2*, Konstantinos Aliazis, PhD^1*, Rushil Shah^1*, Rinku Pal, BS^1* and Vassiliki A Boussiotis, MD, PhD¹

¹Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
²Medicine, Yale University, New Heaven, CT

Xunhong Cao^1*, Xuying Pei, PhD^2*, Qiannan Shang^3*, Xiangyu Zhao, M.D, Ph.D⁴ and Xiaojun Huang, MD^5*

¹Institute of Hematology, Peking University People's Hospital, Beijing, AL, China
²Peking University of People's Hospital, Beijing, CHN
³Institute of Hematology, Peking University People's Hospital, Beijing, China
⁴Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
⁵Peking University People’s Hospital,Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China

Sayaka Sano^1*, Hiroki Kato^1*, Yan Yan^1*, Eijiro Furukawa^1*, Daigo Michimata^1*, Yuya Tanaka^1*, Kazuki Sakurai^1*, Koichi Onodera^1*, Satoshi Ichikawa^1*, Noriko Fukuhara¹, Yasushi Onishi^1*, Hisayuki Yokoyama^1*, Tohru Fujiwara^1,2 and Hideo Harigae¹

¹Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
²Department of Laboratory Medicine, Iwate Medical University School of Medicine, Shiwa-gun, Iwate, Japan

Melanie Märklin, PhD^1,2*, Samuel Holzmayer^1,2*, Martin R. Mueller, MD, PhD^3* and Helmut R. Salih, MD^1,2*

¹Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany
²DFG Cluster of Excellence 2180 'Image-guided and Functional Instructed Tumor Therapy' (iFiT), University of Tuebingen, Tuebingen, Germany
³Dept. of Hematology, Oncology and Immunology, Klinikum Region Hannover, KRH Klinikum Siloah, Hannover, DEU

Swamroop V Nandwani^1*, Alexander J. Didier¹, Alan Fahoury^2*, Daniel J Craig, MD, PhD^3*, Caleb T Spencer, MD^3*, Dean Watkins^1* and Divya Vijendra^4*

¹University of Toledo College of Medicine and Life Sciences, Toledo, OH
²University of Toledo College of Medicine, Toledo, OH
³Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH
⁴University of Toledo College of Medicine and Life Sciences, Toledo

Juan Xie, PhD^1*, Ming Zhao^2*, Yiyang Ding, M.D.^2*, Qiannan Shang^2*, Xunhong Cao^1* and Xiangyu Zhao, M.D, Ph.D^3,4

¹Institute of Hematology, Peking University People's Hospital, Beijing, AL, China
²Institute of Hematology, Peking University People's Hospital, Beijing, China
³Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
⁴Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China